<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82373">
  <stage>Registered</stage>
  <submitdate>24/10/2007</submitdate>
  <approvaldate>29/10/2007</approvaldate>
  <actrnumber>ACTRN12607000556448</actrnumber>
  <trial_identification>
    <studytitle>Contraceptive trial in healthy young women in which the use of a radiopaque etonogestrel implant inserted with a next generation applicator is evaluated.</studytitle>
    <scientifictitle>An open-label, non-controlled multicentre trial to evaluate the insertion characteristics of the radiopaque etonogestrel implant using a next generation applicator.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Contraception</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Contraception</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Radiopaque Etonogestrel Implant for three years, no control treatment.</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To evaluate the use of the next generation applicator and its instructions for proper insertion of the Radiopaque Implant.</outcome>
      <timepoint>Insertion visit.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To evaluate the removal of the Radiopaque Implant, to assess overall contraceptive efficay and safety, to assess X-ray visibility of the Radiopaque Implant, to evaluate subject's expactations and satisfaction with the Radiopaque Implant.</outcome>
      <timepoint>3 years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women 18-40 years, good physical and mental health, having regular menstrual cycles with a usual length between 24 and 35 days and a body mass index between 18 and 35 kg/m2.   Subjects who are not willing to give written consent will not be allowed to enter.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Contraindications for contraceptives, hypertension, history during pregnancy or during previous use of of sex steroids of a.o. jaundice, gallstone formation, porphyria, hemolytic uremic syndrome, use of drugs that may interfere with the pharmacokinetics of sex steroids.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>23/04/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>France</country>
      <state>UK</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Sweden</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>NV Organon</primarysponsorname>
    <primarysponsoraddress>Molenstraat 110
5342 CC Oss</primarysponsoraddress>
    <primarysponsorcountry>Netherlands</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>NV Organon</fundingname>
      <fundingaddress>Molenstraat 110
5342 CC Oss</fundingaddress>
      <fundingcountry>Netherlands</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Southern Health Human Research Ethics Committee</ethicname>
      <ethicaddress>Monash Medical Centre
246 Clayton Road
Clayton VIC 3168</ethicaddress>
      <ethicapprovaldate>19/03/2007</ethicapprovaldate>
      <hrec>06190C</hrec>
      <ethicsubmitdate>21/12/2006</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Mommers, Ellen, PhD</name>
      <address>P.O. Box 20
5340 BH Oss</address>
      <phone>+31 (0) 4123712</phone>
      <fax />
      <email>ellen.mommers@organon.com</email>
      <country>Netherlands</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mommers, Ellen, PhD</name>
      <address>P.O. Box 20
5340 BH Oss</address>
      <phone>+31(0)4123712</phone>
      <fax />
      <email>ellen.mommers@organon.com</email>
      <country>Netherlands</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Penelope Diakos</name>
      <address>Unit A
31-33 Sirius Road
Lane Cove NSW</address>
      <phone>+61 2 94289418</phone>
      <fax />
      <email>penelope.diakos@organon.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>